Upgrade to SI Premium - Free Trial

Editas Medicine (EDIT) PT Lowered to $15 at Citi

May 8, 2024 4:01 PM
Citi analyst Samantha Semenkow lowered the price target on Editas Medicine (NASDAQ: EDIT) to $15.00 (from $16.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change

Next Articles